Assessment of mycotoxin exposure in breastfeeding mothers with celiac disease

Francesco Valitutti, Barbara De Santis, Chiara Maria Trovato, Monica Montuori, Simona Gatti, Salvatore Oliva, Carlo Brera, Carlo Catassi

Research output: Contribution to journalArticle

Abstract

Objective: To assess the risk of mycotoxin exposure (aflatoxin M1, ochratoxin A, and zearalenone) in celiac disease (CD) breastfeeding mothers and healthy control mothers, as well as in their offspring, by quantifying these contaminants in breast milk. Study design: Thirty-five breastfeeding women with CD on a gluten-free diet and 30 healthy breastfeeding controls were recruited. Milk sampling was performed three times per day for three consecutive days. Mycotoxin content was investigated by an analytical method using immunoaffinity column clean-up and high-performance liquid chromatography (HPLC) with fluorometric detection. Results: Aflatoxin M1 (AFM1) was detected in 37% of CD group samples (mean ± SD = 0.012 ± 0.011 ng/mL; range = 0.003-0.340 ng/mL). The control group showed lower mean AFM1 concentration levels in 24% of the analyzed samples (0.009 ± 0.007 ng/mL; range = 0.003-0.067 ng/mL, ANOVA on ranks, p-value < 0.01). Ochratoxin A and zearalenone did not differ in both groups. Conclusion: Breast milk AFM1 contamination for both groups is lower than the European safety threshold. However, the estimated exposures of infants from CD mothers and control mothers was much higher (≃15 times and ≃11 times, respectively) than the threshold set by the joint FAO/WHO Expert Committee on Food Additives (JECFA). Since incongruities exist between JECFA and the European Union standard, a novel regulatory review of the available data on this topic is desirable. Protecting babies from a neglected risk of high AFM1 exposure requires prompt regulatory and food-control policies.

Original languageEnglish
Article number336
JournalNutrients
Volume10
Issue number3
DOIs
Publication statusPublished - Mar 10 2018

Fingerprint

Aflatoxin M1
aflatoxin M1
celiac disease
Mycotoxins
breast feeding
Celiac Disease
Breast Feeding
mycotoxins
Mothers
Zearalenone
Food Additives
zearalenone
ochratoxin A
food additives
Human Milk
breast milk
committees
Joints
gluten-free diet
Gluten-Free Diet

Keywords

  • Breast milk
  • Celiac disease
  • Mycotoxins

ASJC Scopus subject areas

  • Food Science
  • Nutrition and Dietetics

Cite this

Valitutti, F., De Santis, B., Trovato, C. M., Montuori, M., Gatti, S., Oliva, S., ... Catassi, C. (2018). Assessment of mycotoxin exposure in breastfeeding mothers with celiac disease. Nutrients, 10(3), [336]. https://doi.org/10.3390/nu10030336

Assessment of mycotoxin exposure in breastfeeding mothers with celiac disease. / Valitutti, Francesco; De Santis, Barbara; Trovato, Chiara Maria; Montuori, Monica; Gatti, Simona; Oliva, Salvatore; Brera, Carlo; Catassi, Carlo.

In: Nutrients, Vol. 10, No. 3, 336, 10.03.2018.

Research output: Contribution to journalArticle

Valitutti, Francesco ; De Santis, Barbara ; Trovato, Chiara Maria ; Montuori, Monica ; Gatti, Simona ; Oliva, Salvatore ; Brera, Carlo ; Catassi, Carlo. / Assessment of mycotoxin exposure in breastfeeding mothers with celiac disease. In: Nutrients. 2018 ; Vol. 10, No. 3.
@article{31a65849181a4e419b9ae3ddadc93982,
title = "Assessment of mycotoxin exposure in breastfeeding mothers with celiac disease",
abstract = "Objective: To assess the risk of mycotoxin exposure (aflatoxin M1, ochratoxin A, and zearalenone) in celiac disease (CD) breastfeeding mothers and healthy control mothers, as well as in their offspring, by quantifying these contaminants in breast milk. Study design: Thirty-five breastfeeding women with CD on a gluten-free diet and 30 healthy breastfeeding controls were recruited. Milk sampling was performed three times per day for three consecutive days. Mycotoxin content was investigated by an analytical method using immunoaffinity column clean-up and high-performance liquid chromatography (HPLC) with fluorometric detection. Results: Aflatoxin M1 (AFM1) was detected in 37{\%} of CD group samples (mean ± SD = 0.012 ± 0.011 ng/mL; range = 0.003-0.340 ng/mL). The control group showed lower mean AFM1 concentration levels in 24{\%} of the analyzed samples (0.009 ± 0.007 ng/mL; range = 0.003-0.067 ng/mL, ANOVA on ranks, p-value < 0.01). Ochratoxin A and zearalenone did not differ in both groups. Conclusion: Breast milk AFM1 contamination for both groups is lower than the European safety threshold. However, the estimated exposures of infants from CD mothers and control mothers was much higher (≃15 times and ≃11 times, respectively) than the threshold set by the joint FAO/WHO Expert Committee on Food Additives (JECFA). Since incongruities exist between JECFA and the European Union standard, a novel regulatory review of the available data on this topic is desirable. Protecting babies from a neglected risk of high AFM1 exposure requires prompt regulatory and food-control policies.",
keywords = "Breast milk, Celiac disease, Mycotoxins",
author = "Francesco Valitutti and {De Santis}, Barbara and Trovato, {Chiara Maria} and Monica Montuori and Simona Gatti and Salvatore Oliva and Carlo Brera and Carlo Catassi",
year = "2018",
month = "3",
day = "10",
doi = "10.3390/nu10030336",
language = "English",
volume = "10",
journal = "Nutrients",
issn = "2072-6643",
publisher = "NLM (Medline)",
number = "3",

}

TY - JOUR

T1 - Assessment of mycotoxin exposure in breastfeeding mothers with celiac disease

AU - Valitutti, Francesco

AU - De Santis, Barbara

AU - Trovato, Chiara Maria

AU - Montuori, Monica

AU - Gatti, Simona

AU - Oliva, Salvatore

AU - Brera, Carlo

AU - Catassi, Carlo

PY - 2018/3/10

Y1 - 2018/3/10

N2 - Objective: To assess the risk of mycotoxin exposure (aflatoxin M1, ochratoxin A, and zearalenone) in celiac disease (CD) breastfeeding mothers and healthy control mothers, as well as in their offspring, by quantifying these contaminants in breast milk. Study design: Thirty-five breastfeeding women with CD on a gluten-free diet and 30 healthy breastfeeding controls were recruited. Milk sampling was performed three times per day for three consecutive days. Mycotoxin content was investigated by an analytical method using immunoaffinity column clean-up and high-performance liquid chromatography (HPLC) with fluorometric detection. Results: Aflatoxin M1 (AFM1) was detected in 37% of CD group samples (mean ± SD = 0.012 ± 0.011 ng/mL; range = 0.003-0.340 ng/mL). The control group showed lower mean AFM1 concentration levels in 24% of the analyzed samples (0.009 ± 0.007 ng/mL; range = 0.003-0.067 ng/mL, ANOVA on ranks, p-value < 0.01). Ochratoxin A and zearalenone did not differ in both groups. Conclusion: Breast milk AFM1 contamination for both groups is lower than the European safety threshold. However, the estimated exposures of infants from CD mothers and control mothers was much higher (≃15 times and ≃11 times, respectively) than the threshold set by the joint FAO/WHO Expert Committee on Food Additives (JECFA). Since incongruities exist between JECFA and the European Union standard, a novel regulatory review of the available data on this topic is desirable. Protecting babies from a neglected risk of high AFM1 exposure requires prompt regulatory and food-control policies.

AB - Objective: To assess the risk of mycotoxin exposure (aflatoxin M1, ochratoxin A, and zearalenone) in celiac disease (CD) breastfeeding mothers and healthy control mothers, as well as in their offspring, by quantifying these contaminants in breast milk. Study design: Thirty-five breastfeeding women with CD on a gluten-free diet and 30 healthy breastfeeding controls were recruited. Milk sampling was performed three times per day for three consecutive days. Mycotoxin content was investigated by an analytical method using immunoaffinity column clean-up and high-performance liquid chromatography (HPLC) with fluorometric detection. Results: Aflatoxin M1 (AFM1) was detected in 37% of CD group samples (mean ± SD = 0.012 ± 0.011 ng/mL; range = 0.003-0.340 ng/mL). The control group showed lower mean AFM1 concentration levels in 24% of the analyzed samples (0.009 ± 0.007 ng/mL; range = 0.003-0.067 ng/mL, ANOVA on ranks, p-value < 0.01). Ochratoxin A and zearalenone did not differ in both groups. Conclusion: Breast milk AFM1 contamination for both groups is lower than the European safety threshold. However, the estimated exposures of infants from CD mothers and control mothers was much higher (≃15 times and ≃11 times, respectively) than the threshold set by the joint FAO/WHO Expert Committee on Food Additives (JECFA). Since incongruities exist between JECFA and the European Union standard, a novel regulatory review of the available data on this topic is desirable. Protecting babies from a neglected risk of high AFM1 exposure requires prompt regulatory and food-control policies.

KW - Breast milk

KW - Celiac disease

KW - Mycotoxins

UR - http://www.scopus.com/inward/record.url?scp=85044067733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044067733&partnerID=8YFLogxK

U2 - 10.3390/nu10030336

DO - 10.3390/nu10030336

M3 - Article

C2 - 29534461

AN - SCOPUS:85044067733

VL - 10

JO - Nutrients

JF - Nutrients

SN - 2072-6643

IS - 3

M1 - 336

ER -